Cross Country Healthcare (CCRN) PT Raised to $18.61 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
William Blair Downgrades Cross Country Healthcare (CCRN) to Market Perform
December 4, 2024 11:07 AM ESTWilliam Blair analyst Trevor Romeo downgraded Cross Country Healthcare (NASDAQ: CCRN) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Cross Country Healthcare click here. For more ratings news on Cross Country Healthcare click here.
Shares of Cross Country Healthcare closed at $11.16 yesterday.
... MoreBenchmark Downgrades Cross Country Healthcare (CCRN) to Hold
December 4, 2024 9:54 AM ESTBenchmark analyst Bill Sutherland downgraded Cross Country Healthcare (NASDAQ: CCRN) from Buy to Hold.
For an analyst ratings summary and ratings history on Cross Country Healthcare click here. For more ratings news on Cross Country Healthcare click here.
Shares of Cross Country Healthcare closed at $11.16 yesterday.
... MoreAya Healthcare to Acquire Cross Country Healthcare (CCRN) for Approximately $615 Million in Cash
December 4, 2024 7:45 AM ESTAya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at approximately $615 million. The all-cash transaction represents a premium of 67 percent to Cross Countrys closing price on December 3, 2024, and a premium of 68 percent to the volume-weighted average trading price for the 30-day trading period ended December 3, 2024.
Aya and Cross Country offer complementary, tech-enabled workforce solutions across the continuum of care. The proposed combination will diversify Ayas coverage to include Cross Countrys clinical services in non-clinical... More
